Patient-reported Outcome Measures and Decision Regret After Prostate-specific Membrane Antigen–targeted Radioguided Surgery for Oligorecurrent Prostate Cancer
No significant deterioration in health-related quality of life was reported after removing early prostate cancer metastases. Very few patients expressed remorse about their decision for salvage surgery.
Authors
- Zhe Tian (ORCID: https://orcid.org/0000-0002-9482-6473)
- Fabian Falkenbach (ORCID: https://orcid.org/0000-0003-1907-3982)
- Daniel Köehler (ORCID: https://orcid.org/0000-0003-2940-7050)
- Giovanni Mazzucato (ORCID: https://orcid.org/0009-0004-3407-9869)
- Lars Budäus
- Derya Tilki (ORCID: https://orcid.org/0000-0001-7033-1380)
- Tobias Maurer (ORCID: https://orcid.org/0000-0002-5660-7691)
- Sophie Knipper (ORCID: https://orcid.org/0000-0002-2681-3611)
- Pierre Tennstedt (ORCID: https://orcid.org/0000-0001-9237-3442)
- Thomas Steuber
- Pierre I. Karakiewicz (ORCID: https://orcid.org/0000-0003-1354-5854)
- Burkhard Beyer (ORCID: https://orcid.org/0000-0002-4077-3708)
- Markus Graefen
Institutions
- University of Verona (IT)
- Universität Hamburg (DE)
- Azienda Ospedaliera Universitaria Integrata Verona (IT)
- University Medical Center Hamburg-Eppendorf (DE)
- Vivantes Klinikum (DE)
- Martini-Klinik (DE)
- Werner-Wicker-Klinik (DE)
- Université de Montréal (CA)
Publication Details
- Journal
- European Urology Open Science
- Published
- 2024-10-10
- DOI
- https://doi.org/10.1016/j.euros.2024.09.010
- Citations
- 6
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.51